The HCPLive Cardiology condition center page is a comprehensive resource for clinical news and insights on cardiovascular and cardiometabolic diseases. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for heart disease and cardiovascular events, as well as associated diabetes, renal failure, and more...
October 25th 2024
New research indicates semaglutide reduced albuminuria and body weight in CKD patients without diabetes, highlighting its potential renal benefits.
Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes
View More
‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
Health Coach-Based Primary Care Programs Linked to Reduced Cardiovascular Risk
February 9th 2021An intervention implementing the use of a health coach in a primary care setting based on the 2013 AHA/ACC/Task Force for the Management of Overweight and Obesity in Adults guidelines was associated with greater weight loss and improvements in blood glucose levels and HDL-C compared to usual care.
HbA1c Swings After Initial Diabetes Diagnosis Helps Predict CVD Risk
February 6th 2021An analysis of nearly 30k patients from the LEAD study suggests increased HbA1c variability within the first 2 years of a diabetes diagnosis was associated with a 30-59% increase in risk of incident cardiovascular disease.
HbA1c Variability in First Two Years After Diabetes Diagnosis Helps Predict CVD Risk
February 4th 2021An analysis of 29k patients with type 2 diabetes suggests increased HbA1c variability within the first 2 years of a diabetes diagnosis was associated with a 30-59% increase in risk of incident cardiovascular disease.
Gestational Diabetes Raises Long-Term Heart Attack Risk, Regardless of Post-Birth Glycemic Control
February 3rd 2021An analysis of data obtained from the CARDIA study offers insight into the subsequent cardiovascular risks associated with gestational diabetes and how glucose control after pregnancy impacts this apparent increase risk.
Polypill, Aspirin Combo Reduces Risk of Cardiovascular Disease
Low-density lipoprotein cholesterol level was lower by approximately 19 mg per deciliter and systolic blood pressure was lower by approximately 5.8 mm Hg with the polypill and with combination therapy than with placebo.
Intravenous Alcohol Has Immediate Effect on Cardiac Electrophysiology, Trial Finds
January 29th 2021Results of the How Alcohol Induces Atrial Tachyarrhythmias (HOLIDAY) trial offer insight into the effects of alcohol on cardiac electrophysiology from a randomized, double-blind, placebo-controlled trial.